— Know what they know.
Not Investment Advice

AKBA NASDAQ

Akebia Therapeutics, Inc.
1W: -9.7% 1M: -28.2% 3M: -13.6% YTD: -34.2% 1Y: -65.1% 3Y: -2.9% 5Y: -70.4%
$1.02
+0.00 (+0.00%)
 
Weekly Expected Move ±11.9%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 29 · $273.6M mcap · 262M float · 1.38% daily turnover · Short 31% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
45.8 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 6.5%
Cost Advantage ★
59
Intangibles
44
Switching Cost
50
Network Effect
43
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. AKBA shows a Weak competitive edge (45.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 6.5% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$4
Avg Target
$4
High
Based on 1 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 7Hold: 3Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$4.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-06 Piper Sandler Allison Bratzel Initiated $4 +189.9% $1.38
2024-03-28 H.C. Wainwright Ed Arce Initiated $6 +203.0% $1.98
2022-03-02 Needham Serge Belanger Initiated $7 +164.2% $2.65

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. AKBA receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

37 Grade D
Profitability
20
Balance Sheet
32
Earnings Quality
22
Growth
88
Value
10
Momentum
80
Safety
0
Cash Flow
60
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. AKBA scores highest in Growth (88/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-4.91
Distress Zone
Piotroski F-Score
4/9
Beneish M-Score
-2.89
Unlikely Manipulator
Ohlson O-Score
-3.97
Bankruptcy prob: 1.9%
Low Risk
Credit Rating
CCC
Score: 15.2/100
Trend: Improving
Earnings Quality
OCF/NI: -2.94x
Accruals: -27.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AKBA scores -4.91, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AKBA scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. AKBA's score of -2.89 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AKBA's implied 1.9% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AKBA receives an estimated rating of CCC (score: 15.2/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-13.11x
PEG
0.01x
P/S
1.16x
P/B
9.83x
P/FCF
6.19x
P/OCF
6.15x
EV/EBITDA
127.30x
EV/Revenue
1.73x
EV/EBIT
214.17x
EV/FCF
6.71x
Earnings Yield
-5.53%
FCF Yield
16.17%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. AKBA currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.093
NI / EBT
×
Interest Burden
-9.979
EBT / EBIT
×
EBIT Margin
0.008
EBIT / Rev
×
Asset Turnover
0.778
Rev / Assets
×
Equity Multiplier
-36.032
Assets / Equity
=
ROE
247.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AKBA's ROE of 247.5% is driven by Asset Turnover (0.778), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.09 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1.02
Median 1Y
$0.43
5th Pctile
$0.07
95th Pctile
$2.66
Ann. Volatility
107.3%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
John P. Butler,
President and Chief Executive Officer
$864,010 $2,164,338 $5,652,339
Steven K. Burke,
M.D., Senior Vice President, Chief Research & Development and Medical Officer
$600,538 $436,576 $1,859,815
Erik J. Ostrowski,
Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer
$552,919 $436,576 $1,792,361
Nicholas P. Grund,
Senior Vice President, Chief Commercial Officer
$506,742 $436,576 $1,728,405

CEO Pay Ratio

2104:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $5,652,339
Avg Employee Cost (SGA/emp): $2,687
Employees: 40,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
40,000
+21999.5% YoY
Revenue / Employee
$5,905
Rev: $236,196,000
Profit / Employee
$-134
NI: $-5,345,000
SGA / Employee
$2,687
Avg labor cost proxy
R&D / Employee
$1,559
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -93.3% -93.1% -1.8% -1.7% -1.0% -97.6% -2.4% -1.5% -2.5% -1.5% 4.1% 3.4% 3.2% 3.6% 1.7% 1.1% 91.5% 39.9% 64.5% 2.5% 2.47%
ROA -42.3% -42.3% -48.1% -46.8% -27.7% -26.7% -21.4% -13.3% -22.5% -13.6% -17.4% -14.4% -13.5% -15.4% -30.0% -19.6% -15.8% -6.9% -1.8% -6.9% -6.87%
ROIC -2.2% -2.1% -3.5% -3.4% -1.9% -1.8% -4.4% -2.6% -5.0% -2.9% -1.2% -91.7% -91.0% -89.6% -45.5% -19.8% 0.7% 16.0% 29.0% 6.5% 6.52%
ROCE -56.0% -55.3% -94.9% -92.2% -50.2% -48.6% -28.8% -14.7% -34.1% -17.7% -32.4% -24.6% -23.7% -23.9% -37.1% -16.9% -6.0% 7.8% 9.6% 0.9% 0.88%
Gross Margin 0.8% 67.3% 45.0% 49.2% 85.3% 21.4% 1.1% 49.5% 69.3% 57.2% 66.8% 91.7% 81.0% 62.2% 56.2% 86.7% 84.1% 83.5% 78.8% 76.4% 76.43%
Operating Margin -1.5% -1.1% -1.1% -94.8% 27.0% -1.0% -11.5% -64.0% -16.0% -31.0% 2.4% -45.8% -20.0% -33.4% -30.8% 23.6% 22.6% 7.6% -14.8% -8.8% -8.77%
Net Margin -1.6% -1.2% -1.2% -1.0% 23.3% -1.1% -13.7% -67.2% -19.8% -34.5% 1.1% -55.2% -19.7% -53.5% -49.0% 10.7% 0.4% 0.9% -21.2% -16.9% -16.91%
EBITDA Margin -1.3% -92.2% -83.2% -77.7% 34.8% -83.6% 31.2% -39.8% -0.2% -8.7% 20.4% -15.1% 2.7% -10.7% -14.2% 24.8% 11.8% 10.6% -10.6% -8.2% -8.16%
FCF Margin -86.7% -1.1% -1.2% -92.3% -58.2% -27.6% -25.1% -25.6% -17.4% -39.1% -12.0% -13.5% -22.4% -22.7% -25.4% -18.9% -1.3% 14.3% 28.6% 25.8% 25.82%
OCF Margin -86.5% -1.0% -1.2% -92.2% -58.2% -27.6% -25.1% -25.6% -17.4% -39.1% -12.0% -13.5% -22.3% -22.7% -25.4% -18.8% -1.2% 14.4% 28.8% 26.0% 25.98%
ROA 3Y Avg snapshot only -14.59%
ROIC Economic snapshot only 1.71%
Cash ROA snapshot only 16.03%
Cash ROIC snapshot only 94.24%
CROIC snapshot only 93.67%
NOPAT Margin snapshot only 1.80%
Pretax Margin snapshot only -8.07%
R&D / Revenue snapshot only 28.87%
SGA / Revenue snapshot only 48.65%
SBC / Revenue snapshot only 4.34%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -2.04 -1.67 -1.41 -0.47 -0.41 -0.37 -1.12 -1.75 -1.71 -3.57 -4.55 -8.72 -5.29 -6.04 -5.99 -10.24 -27.05 -47.09 -79.93 -18.10 -13.115
P/S Ratio 2.76 2.38 1.88 0.58 0.23 0.20 0.36 0.38 0.85 1.11 1.21 2.00 1.23 1.63 2.59 2.51 4.84 3.33 1.81 1.60 1.163
P/B Ratio 2.47 2.02 5.36 1.74 0.91 0.79 20.30 19.78 32.68 41.05 -7.72 -12.26 -6.99 -9.08 -8.45 -9.43 -20.06 -15.23 13.10 11.38 9.826
P/FCF -3.18 -2.26 -1.57 -0.63 -0.39 -0.71 -1.45 -1.50 -4.91 -2.83 -10.10 -14.84 -5.48 -7.21 -10.21 -13.30 -386.84 23.28 6.32 6.19 6.186
P/OCF 23.12 6.28 6.15 6.148
EV/EBITDA -2.10 -1.65 -1.76 -0.55 -0.55 -0.48 -4.19 25.16 -4.56 -89.42 -35.99 159.94 68.18 91.50 -38.59 125.28 102.09 41.72 21.11 127.30 127.300
EV/Revenue 2.11 1.70 1.81 0.52 0.18 0.15 0.40 0.42 0.90 1.16 1.53 2.33 1.58 2.00 3.45 3.25 5.52 3.94 1.94 1.73 1.733
EV/EBIT -1.83 -1.42 -1.50 -0.47 -0.40 -0.34 -1.77 -3.40 -2.33 -5.58 -6.48 -12.51 -8.20 -10.01 -10.66 -25.40 -134.70 80.99 22.42 214.17 214.175
EV/FCF -2.44 -1.62 -1.51 -0.56 -0.31 -0.54 -1.58 -1.63 -5.18 -2.96 -12.72 -17.26 -7.05 -8.80 -13.57 -17.23 -440.49 27.53 6.78 6.71 6.710
Earnings Yield -49.0% -59.8% -71.1% -2.1% -2.4% -2.7% -89.1% -57.1% -58.3% -28.0% -22.0% -11.5% -18.9% -16.6% -16.7% -9.8% -3.7% -2.1% -1.3% -5.5% -5.53%
FCF Yield -31.5% -44.2% -63.8% -1.6% -2.6% -1.4% -69.0% -66.8% -20.3% -35.3% -9.9% -6.7% -18.2% -13.9% -9.8% -7.5% -0.3% 4.3% 15.8% 16.2% 16.17%
PEG Ratio snapshot only 0.014
EV/OCF snapshot only 6.669
EV/Gross Profit snapshot only 2.142
Acquirers Multiple snapshot only 76.130
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.98 1.98 1.04 1.04 1.04 1.04 1.43 1.43 1.43 1.43 1.18 1.18 1.18 1.18 1.41 1.41 1.41 1.41 1.13 1.13 1.134
Quick Ratio 1.66 1.66 0.90 0.90 0.90 0.90 1.26 1.26 1.26 1.26 1.03 1.03 1.03 1.03 1.21 1.21 1.21 1.21 1.04 1.04 1.039
Debt/Equity 0.51 0.51 1.84 1.84 1.84 1.84 19.08 19.08 19.08 19.08 -3.41 -3.41 -3.41 -3.41 -3.84 -3.84 -3.84 -3.84 6.63 6.63 6.633
Net Debt/Equity -0.58 -0.58 -0.19 -0.19 -0.19 -0.19 1.78 1.78 1.78 1.78 0.96 0.96 0.965
Debt/Assets 0.20 0.20 0.26 0.26 0.26 0.26 0.28 0.28 0.28 0.28 0.43 0.43 0.43 0.43 0.86 0.86 0.86 0.86 0.57 0.57 0.574
Debt/EBITDA -0.57 -0.58 -0.63 -0.65 -1.40 -1.47 -3.62 22.26 -2.52 -39.83 -12.61 38.19 25.81 28.13 -13.18 39.36 17.15 8.89 9.96 68.38 68.384
Net Debt/EBITDA 0.64 0.66 0.06 0.07 0.14 0.15 -0.34 2.08 -0.24 -3.72 -7.41 22.45 15.18 16.54 -9.56 28.54 12.43 6.45 1.45 9.94 9.944
Interest Coverage -17.81 -14.71 -12.78 -12.25 -6.65 -6.82 -4.16 -2.72 -8.78 -6.42 -7.61 -5.00 -4.49 -2.66 -2.85 -1.01 -0.30 0.42 0.85 0.16 0.160
Equity Multiplier 2.60 2.60 7.15 7.15 7.15 7.15 68.08 68.08 68.08 68.08 -7.90 -7.90 -7.90 -7.90 -4.49 -4.49 -4.49 -4.49 11.55 11.55 11.548
Cash Ratio snapshot only 1.134
Debt Service Coverage snapshot only 0.270
Cash to Debt snapshot only 0.855
FCF to Debt snapshot only 0.277
Defensive Interval snapshot only 463.3 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.31 0.30 0.36 0.38 0.50 0.50 0.66 0.61 0.45 0.44 0.65 0.63 0.58 0.57 0.69 0.80 0.88 0.97 0.79 0.78 0.778
Inventory Turnover 1.63 1.46 2.76 2.69 2.00 2.46 2.93 2.54 2.50 1.80 3.98 3.04 2.56 2.35 2.85 3.16 3.26 2.98 2.48 2.79 2.791
Receivables Turnover 6.58 6.25 5.28 5.52 7.35 7.35 6.36 5.88 4.36 4.22 4.89 4.71 4.39 4.27 4.35 5.02 5.53 6.11 5.80 5.71 5.710
Payables Turnover 3.58 3.23 3.60 3.51 2.61 3.20 3.30 2.87 2.82 2.03 4.54 3.47 2.92 2.68 3.05 3.38 3.49 3.19 2.17 2.44 2.445
DSO 55 58 69 66 50 50 57 62 84 87 75 78 83 85 84 73 66 60 63 64 63.9 days
DIO 224 249 132 136 183 149 125 144 146 203 92 120 143 155 128 116 112 122 147 131 130.8 days
DPO 102 113 101 104 140 114 111 127 130 180 80 105 125 136 119 108 104 114 168 149 149.3 days
Cash Conversion Cycle 178 195 100 98 92 84 72 78 100 110 86 92 101 105 92 80 73 68 42 45 45.4 days
Operating Cycle snapshot only 194.7 days
Cash Velocity snapshot only 1.257
Capital Intensity snapshot only 1.620
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -34.8% -31.6% -28.3% -14.7% 32.7% 39.8% 37.9% 22.3% -32.0% -34.2% -33.3% -30.7% -12.9% -12.3% -17.7% -1.2% 16.8% 32.5% 47.5% 25.7% 25.68%
Net Income 22.3% 23.5% 26.5% 29.9% 45.8% 47.5% 66.4% 78.5% 38.6% 61.7% 45.1% 27.2% 59.4% 23.5% -33.7% -5.3% 9.8% 65.4% 92.3% 54.7% 54.73%
EPS 34.1% 36.9% 39.2% 40.0% 54.1% 50.4% 68.0% 79.1% 37.4% 62.6% 47.0% 34.3% 63.9% 31.5% -16.4% 10.7% 30.2% 73.5% 93.7% 59.0% 59.05%
FCF -41.1% -28.6% -1.3% -1.2% 10.8% 63.2% 71.0% 66.1% 79.7% 6.9% 68.1% 63.4% -12.1% 49.1% -74.0% -37.9% 93.5% 1.8% 2.7% 2.7% 2.72%
EBITDA 31.3% 34.2% 30.3% 33.9% 56.5% 57.2% 87.3% 1.0% 59.2% 97.3% 70.0% -39.1% 1.1% 2.5% -73.2% 75.8% 1.7% 4.7% 2.5% -34.0% -34.04%
Op. Income 25.0% 26.3% 29.7% 32.5% 49.7% 50.7% 69.3% 81.3% 36.8% 61.5% 43.0% 26.3% 61.3% 35.5% -9.1% 38.1% 1.0% 1.5% 1.5% 1.2% 1.24%
OCF Growth snapshot only 2.73%
Asset Growth snapshot only 70.65%
Debt Growth snapshot only 14.61%
Shares Change snapshot only 10.53%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -0.2% -3.6% 0.6% -1.9% 0.9% -3.3% -4.5% -8.3% -16.2% -14.4% -13.0% -10.3% -7.7% -6.9% -8.9% -5.8% -11.6% -8.6% -6.8% -4.9% -4.91%
Revenue 5Y 1.7% 58.1% 42.0% 26.1% 10.4% 5.9% -2.2% -3.8% -1.3% -4.4% -9.4% -12.2% -13.7% -12.0% -9.7% -6.1% -4.4% -2.2% -2.15%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y -11.0% -10.97%
EBITDA 5Y
Gross Profit 3Y 19.1% 12.2% -6.0% -1.7% -6.1% 12.5% 29.2% 49.8% 17.8% 16.0% 14.2% 14.5% -8.3% 0.6% -1.7% -1.4% -1.44%
Gross Profit 5Y 19.8% -1.9% -9.7% -12.0% -10.7% 11.1% 22.1% 40.6%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 20.9% 20.9% -19.0% -19.0% -19.0% -19.0% -22.7% -22.7% -22.7% -22.7% -27.9% -27.9% -27.9% -27.9% -25.3% -25.3% -25.3% -25.3% 1.9% 1.9% 1.88%
Assets 5Y 35.1% 35.1% 12.0% 12.0% 12.0% 12.0% -0.5% -0.5% -0.5% -0.5% -24.7% -24.7% -24.7% -24.7% -22.1% -22.1% -22.1% -22.1% -10.2% -10.2% -10.18%
Equity 3Y 27.5% 27.5% -51.2% -51.2% -51.2% -51.2% -76.3% -76.3% -76.3% -76.3% 84.1% 84.1% 84.06%
Book Value 3Y -9.9% -12.0% -57.4% -57.7% -58.3% -57.8% -79.5% -79.0% -78.7% -78.4% 62.9% 62.8% 62.79%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.60 0.50 0.52 0.44 0.49 0.36 0.14 0.02 0.02 0.05 0.00 0.11 0.53 0.64 0.69 0.78 0.81 0.59 0.46 0.31 0.315
Earnings Stability 0.68 0.65 0.69 0.60 0.19 0.18 0.05 0.01 0.01 0.04 0.28 0.42 0.70 0.76 0.74 0.71 0.93 0.92 0.84 0.78 0.776
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.02 0.13 0.21 0.73 0.77 0.76 0.79 0.68 0.62 0.54 0.41 0.410
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.91 0.91 0.89 0.88 0.82 0.81 0.50 0.50 0.85 0.50 0.82 0.89 0.50 0.91 0.87 0.98 0.96 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend -0.53 -0.50 -2.68 -2.58 -1.10 -1.02 -15.41 -8.65 -17.36 -9.82
Gross Margin Trend -0.02 -0.05 -0.02 0.08 0.36 0.29 0.47 0.54 0.13 0.24 0.08 0.13 0.07 0.08 0.05 0.02 0.06 0.05 0.17 0.10 0.096
FCF Margin Trend -0.20 -0.39 -0.61 -0.44 0.05 0.53 0.53 0.38 0.55 0.27 0.60 0.45 0.15 0.11 -0.07 0.01 0.19 0.45 0.47 0.42 0.420
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.64 0.74 0.90 0.74 1.06 0.52 0.77 1.17 0.35 1.26 0.45 0.59 0.96 0.84 0.59 0.77 0.07 -2.04 -12.72 -2.94 -2.943
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.06 0.99 0.99 0.99 0.994
FCF/Net Income snapshot only -2.926
OCF/EBITDA snapshot only 19.087
CapEx/Revenue 0.2% 0.2% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.2% 0.2% 0.18%
CapEx/Depreciation snapshot only 0.333
Accruals Ratio -0.15 -0.11 -0.05 -0.12 0.02 -0.13 -0.05 0.02 -0.15 0.04 -0.10 -0.06 -0.00 -0.03 -0.12 -0.05 -0.15 -0.21 -0.25 -0.27 -0.271
Sloan Accruals snapshot only -0.041
Cash Flow Adequacy snapshot only 141.386
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.4% 0.3% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -12.8% -18.8% -22.4% -51.8% -43.7% -22.3% -7.1% -0.0% -0.1% -0.0% -2.9% -6.6% -11.6% -9.6% -10.1% -19.2% -9.2% -11.9% -15.6% -0.6% -0.56%
Total Shareholder Return -12.8% -18.8% -22.4% -51.8% -43.7% -22.3% -7.1% -0.0% -0.1% -0.0% -2.9% -6.6% -11.6% -9.6% -10.1% -19.2% -9.2% -11.9% -15.6% -0.6% -0.56%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.04 1.44 1.09 1.093
Interest Burden (EBT/EBIT) 1.17 1.18 1.11 1.11 1.21 1.20 1.45 1.78 1.29 1.50 1.13 1.23 1.21 1.36 1.34 1.92 4.37 -1.40 -0.18 -9.98 -9.979
EBIT Margin -1.15 -1.20 -1.20 -1.12 -0.46 -0.44 -0.22 -0.12 -0.39 -0.21 -0.24 -0.19 -0.19 -0.20 -0.32 -0.13 -0.04 0.05 0.09 0.01 0.008
Asset Turnover 0.31 0.30 0.36 0.38 0.50 0.50 0.66 0.61 0.45 0.44 0.65 0.63 0.58 0.57 0.69 0.80 0.88 0.97 0.79 0.78 0.778
Equity Multiplier 2.20 2.20 3.65 3.65 3.65 3.65 11.17 11.17 11.17 11.17 -23.58 -23.58 -23.58 -23.58 -5.80 -5.80 -5.80 -5.80 -36.03 -36.03 -36.032
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.86 $-1.72 $-1.61 $-1.53 $-0.85 $-0.85 $-0.51 $-0.32 $-0.53 $-0.32 $-0.27 $-0.21 $-0.19 $-0.22 $-0.32 $-0.19 $-0.13 $-0.06 $-0.02 $-0.08 $-0.08
Book Value/Share $1.53 $1.42 $0.42 $0.41 $0.39 $0.40 $0.03 $0.03 $0.03 $0.03 $-0.16 $-0.15 $-0.15 $-0.15 $-0.22 $-0.20 $-0.18 $-0.18 $0.12 $0.12 $0.10
Tangible Book/Share $0.30 $0.28 $-0.53 $-0.52 $-0.49 $-0.51 $-0.68 $-0.68 $-0.67 $-0.67 $-0.66 $-0.61 $-0.60 $-0.60 $-0.49 $-0.45 $-0.40 $-0.39 $-0.10 $-0.10 $-0.10
Revenue/Share $1.38 $1.21 $1.21 $1.23 $1.55 $1.60 $1.59 $1.46 $1.07 $1.03 $1.02 $0.91 $0.83 $0.81 $0.73 $0.77 $0.75 $0.82 $0.89 $0.87 $0.87
FCF/Share $-1.19 $-1.27 $-1.44 $-1.14 $-0.90 $-0.44 $-0.40 $-0.37 $-0.19 $-0.40 $-0.12 $-0.12 $-0.19 $-0.18 $-0.19 $-0.14 $-0.01 $0.12 $0.25 $0.22 $0.22
OCF/Share $-1.19 $-1.27 $-1.44 $-1.13 $-0.90 $-0.44 $-0.40 $-0.37 $-0.19 $-0.40 $-0.12 $-0.12 $-0.19 $-0.18 $-0.19 $-0.14 $-0.01 $0.12 $0.26 $0.23 $0.23
Cash/Share $1.67 $1.55 $0.85 $0.83 $0.79 $0.81 $0.49 $0.49 $0.48 $0.48 $0.23 $0.21 $0.20 $0.20 $0.24 $0.21 $0.19 $0.19 $0.70 $0.69 $0.61
EBITDA/Share $-1.38 $-1.25 $-1.24 $-1.17 $-0.51 $-0.50 $-0.15 $0.02 $-0.21 $-0.01 $-0.04 $0.01 $0.02 $0.02 $-0.07 $0.02 $0.04 $0.08 $0.08 $0.01 $0.01
Debt/Share $0.78 $0.73 $0.77 $0.76 $0.71 $0.74 $0.54 $0.54 $0.53 $0.53 $0.55 $0.51 $0.50 $0.50 $0.86 $0.78 $0.70 $0.69 $0.82 $0.81 $0.81
Net Debt/Share $-0.89 $-0.82 $-0.08 $-0.08 $-0.07 $-0.07 $0.05 $0.05 $0.05 $0.05 $0.32 $0.30 $0.29 $0.29 $0.63 $0.57 $0.50 $0.50 $0.12 $0.12 $0.12
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -4.909
Altman Z-Prime snapshot only -13.028
Piotroski F-Score 4 4 2 3 3 3 5 4 4 3 2 3 4 4 2 3 5 6 6 4 4
Beneish M-Score -66.93 -3.71 -1.96 -2.63 -1.82 -1.25 -3.41 -2.64 -3.35 -2.97 -2.81 -2.97 -2.46 -2.82 -3.18 -2.50 -3.23 -3.53 -2.99 -2.89 -2.889
Ohlson O-Score snapshot only -3.969
Net-Net WC snapshot only $-0.60
EVA snapshot only $-2228090.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only CCC
Credit Score 24.36 24.73 17.73 18.05 18.04 18.43 17.20 8.80 17.20 17.40 19.95 10.79 10.75 10.78 20.00 11.83 11.70 19.29 18.25 15.25 15.249
Credit Grade snapshot only 17
Credit Trend snapshot only 3.415
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 5
Sector Credit Rank snapshot only 5

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms